Next Article in Journal
Insights in the Development and Uses of Alternatives to Antibiotic Growth Promoters in Poultry and Swine Production
Next Article in Special Issue
Predictive Scores for Late-Onset Neonatal Sepsis as an Early Diagnostic and Antimicrobial Stewardship Tool: What Have We Done So Far?
Previous Article in Journal
Empirical Antibiotic Prescribing in Adult COVID-19 Inpatients over Two Years in Mexico
Previous Article in Special Issue
Antibiotic Exposure, Common Morbidities and Main Intestinal Microbial Groups in Very Preterm Neonates: A Pilot Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Persistent Coagulase-Negative Staphylococcal Bacteremia in Neonates: Clinical, Microbiological Characteristics and Changes within a Decade

by
Venetia Bellou
1,†,
Despoina Gkentzi
1,*,†,
Nikolaos Giormezis
2,
Aggeliki Vervenioti
1,
Iris Spiliopoulou
2 and
Gabriel Dimitriou
1
1
Department of Paediatrics, Medical School, University of Patras, Rion, 26504 Patras, Greece
2
Department of Microbiology, Medical School, University of Patras, Rion, 26504 Patras, Greece
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Antibiotics 2022, 11(6), 765; https://doi.org/10.3390/antibiotics11060765
Submission received: 5 May 2022 / Revised: 30 May 2022 / Accepted: 2 June 2022 / Published: 2 June 2022
(This article belongs to the Special Issue Antibiotics and Neonatal Sepsis: Challenges and Opportunities)

Abstract

:
Atypical outbreaks of persistent coagulase-negative staphylococci (CoNS) bacteremias, defined as three or more consecutive positive blood cultures with the same CoNS species, at least 48 h apart, have been reported in neonatal intensive-care units (NICUs). Our aim was to describe the profile of these cases in our NICU over a two-year period with the objective of assessing possible changes within a decade. Demographics, clinical and microbiological data were recorded for all CoNS bacteremias in our tertiary NICU during 2016–2017 and compared with the results of the same study in 2006–2007. Fifty-six cases of CoNS sepsis were recorded. Fourteen (25%) of them were persistent. There were no significant differences in demographic and clinical characteristics between cases with persistent vs. non-persistent bacteremia. Staphylococcus epidermidis was the most common species. In logistic regression analysis, biofilm production (β = 2.464, p = 0.04) was the most significant determinant for the development of persistent CoNS bacteremia. Our isolates were less likely to produce biofilm and carry ica operon as compared to those of 2006–2007. The cases of persistent CoNS sepsis have decreased within a decade, which could be attributed to the implementation of intensive infection control practices. Biofilm production remains the most important risk factor.

1. Introduction

Coagulase-negative staphylococci (CoNS) are a subgroup of staphylococci, which can be distinguished from Staphylococcus aureus and Staphylococcus intermedius by their lack of ability to produce coagulase. Coagulase secretion is a key virulence strategy in the pathogenesis and persistence of staphylococcal diseases and has often been used to distinguish S. aureus from other staphylococci [1]. Staphylococci were historically classified into two groups: one that included S. aureus, considered more pathogenic and thus a “major pathogen,” and a second including other staphylococci that were lumped together as “minor pathogens” and termed the CoNS [1]. Another classification scheme adopted in more recent literature involves grouping all staphylococci other than S. aureus into a single category, non-aureus staphylococci (NAS) [1]. In addition, coagulase-negative variants of S. aureus are known to exist, some of which can have similar pathogenicity to their coagulase-positive variants [1,2]. CoNS are originally described as ubiquitous commensals of the healthy human skin and mucosa. Coagulase-negative staphylococci species, in particular Staphylococcus epidermidis, are among the most important pathogens involved in hospital-associated bloodstream infections and infections related to vascular catheters and prosthetic devices. This is due to the fact that they have higher rates of biofilm production and a higher ability to adjust through genetic exchange [2]. CoNS have been identified as the leading cause of late-onset sepsis (LOS) in neonatal intensive-care units (NICUs) [3,4,5,6,7,8]. Staphylococci can cause up to 90% of LOS in NICUs [3,4,5,6,7,8,9,10]. S. aureus represents around 10% of LOS, whereas the proportion of CoNS ranges from 30% to 60% [8,9,11]. S. epidermidis is the dominant species of CoNS, but other species such as S. capitis, S. haemolyticus, S. hominis and S. warneri have also been reported as pathogens responsible for systemic neonatal infection. CoNS, particularly S. epidermidis, are the most common organisms found in mucocutaneous sites and the nasopharynx during the first week of life [12]. Risk factors reported for CoNS sepsis include extreme prematurity and very low birth weight, as well as the use of intravascular catheters and prolonged parenteral nutrition [9,10,11]. CoNS have been traditionally considered to have low virulence and have not been associated with significant morbidity and mortality [13,14,15].
Atypical outbreaks of persistent CoNS bacteremia, despite aggressive antibiotic therapy, have been reported in NICUs [15,16,17,18,19]. The increasing prevalence of CoNS infection is attributable to their increasing antibiotic resistance and their ability to produce biofilms [19,20]. The biofilm formation facilitates the pathogenicity of CoNS by enhancing their ability to adhere to surfaces of invasive devices such as pacemakers, catheters and prosthetic heart valves, as well as smooth plastic and tissue surfaces [21,22]. This mechanism is vital for the persistence of CoNS, as biofilm-producing strains are characterized by greater resistance to antibiotics. The bacterial cells within the biofilm are embedded in an exopolysaccharide matrix, which affords the bacterial population protection from host defense mechanisms and antimicrobial agents [20]. The biofilm of CoNS is composed of the layer of an extracellular polymeric substance called polysaccharide intercellular adhesion (PIA) matrix, which is encoded by ica operon (icaA, icaB icaC and icaD genes) [23]. The PIA mediates the intercellular adherence of bacteria and the multilayer accumulation of the biofilm, making them resistant to antimicrobial agents and to the immunological response of the host [23,24,25,26].
In our previous report, persistent CoNS sepsis was not related to most of the known clinical risk factors, and it was associated with severe thrombocytopenia. Isolates associated with persistent bacteremia were more likely to produce biofilm, independently of the presence of the ica operon [17].
We hypothesized that the implementation of infection control practices and antimicrobial stewardship interventions might have led to changes in the characteristics of persistent CoNS bacteremia throughout the years. Therefore, the aim of the present study was to describe the clinical and microbiological profile of cases with persistent CoNS bacteremia in our NICU during a two-year period and compare our findings with the ones of the study conducted a decade ago in the same setting with the view of assessing trends over time.

2. Results

During the study period (2016–2017), 56 cases of neonates with late-onset CoNS sepsis were identified (7.4% of all NICU admissions). Of them, 14 (25%) cases with persistent bacteremia were recorded. None of the neonates died from these bacteremias, either persistent or not. The demographics, clinical and laboratory characteristics of these cases are shown in Table 1. No differences were demonstrated between the two groups in terms of demographics and clinical risk factors. The percentage of cases though with persistent bacteremia in our study was lower as compared to 2006–2007, 25% vs. 40%, respectively (p = 0.05). With regards to laboratory indices, the maximum CRP values were higher in the persistent bacteremia group. A comparison with the respective cases during 2006–2007 is shown in Table 2 (for all cases) and Table 3 (cases with persistent vs. non-persistent bacteremia). There were no significant differences in demographic characteristics between the two study periods. Of note though, during 2006–2007, the presence of central indwelling catheters was more frequently recorded as compared to the current study (Table 2 and Table 3).
Out of a total of 167 CoNS isolates, S. epidermidis predominated in 55.4% of the cases, followed by S. haemolyticus (33.9%), S. hominis (7.1%), S. capitis (1.8%) and S. lugdunensis (1.8%). An average of seven positive blood cultures with the same isolate per case were identified in the group with persistent CoNS bacteremias vs. 1.6 isolates per case in the group with non-persistent bacteremias. Nearly half of the isolates were either biofilm-positive or ica operon-positive (Table 4). The presence of either of them was not associated statistically significantly with the development of persistent bacteremia, although the percentages of isolates that were ica or biofilm-positives were higher in the persistent group (Table 4). We compared the molecular characteristics of the CoNS isolates (ica operon, biofilm production, mecA gene presence) between our study period and 2006–2007 (Table 4), and we found that isolates in the present study were less likely to carry ica operon or to produce biofilm.
Table 5 shows the results of the binary logistic regression analysis of factors that might predict persistent CoNS bacteremia (dependent variable). For the purpose of this analysis, we used as independent variables the following parameters: intubation, presence of central indwelling catheters, severe thrombocytopenia and biofilm production. We used these factors because these parameters were found to be major determinants of persistent CοNS bacteremias in 2006–2007 [15] and were widely regarded as being linked to infections difficult to manage [11,13,14,15,16,17]. The analysis showed that severe thrombocytopenia and CoNS biofilm production both had a significant effect on the modeling of dependent variable values (p = 0.005 and p = 0.042, respectively). In particular, based on the corresponding factor value (e3.587 = 36.139), the relative probability of a neonate with severe thrombocytopenia being diagnosed with persistent CoNS bacteremia is approximately 36-fold higher than that of a neonate without severe thrombocytopenia, irrespective of other factors. In addition, the relative probability of a CoNS isolate with biofilm causing persistent CoNS bacteremia is 11-fold higher (1074.0%) than that of a CoNS isolate with no biofilm, irrespective of other factors. The variability of the dependent variable, which is, in our case, the persistent CoNS bacteremia, can be explained by 63% (R2 = 0.630).

3. Discussion

In the present study, we found that the number of cases with persistent CoNS bacteremia has decreased as compared to a similar study conducted ten years ago in the same NICU. We also found that CoNS isolates were less likely to carry ica operon and to produce biofilm. In both periods, the most common species was S. epidermidis, followed by S. haemolyticus and S. hominis, which is in accordance with other studies [14,15,16,17,18,19,27]. None of the neonates in our study died, which is in keeping with most published studies and suggests that CoNS have relatively low virulence and are not associated with significant morbidity [13,14].
The reduction in the number of cases with persistent bacteremia in our study could be attributed to stricter infection control practices and antimicrobial stewardship interventions that have been gradually implemented throughout the ten-year period. Optimal strategies to prevent late-onset sepsis include well-structured infection control protocols, less invasive interventions, rational, empirical antibiotic use, hand hygiene and early feeding with breast milk [28]. All the above have been introduced gradually worldwide and in our NICU within a decade and might have led to an overall reduction in healthcare-associated infections. Of note, in 2020–2021, we had 93 cases with CoNS bacteremia in our NICU (19 cases with persistent bacteremia and 74 cases with non-persistent bacteremia). The percentage of persistent CoNS bacteremia during the period 2021–2022 was 20%, which is lower than the percentage of persistent CoNS bacteremia during 2016–2017 (25%), as well as 2006–2007 (40%). Unfortunately, we do not have microbiological data for the period 2020–2021, but there is a trend toward less persistent CoNS bacteremia within the years.
As for the demographics of our participants, it is of interest to note that there were no differences between those belonging to the persistent and those in the non-persistent groups. Given the fact that very low birth weight and extreme prematurity are important risk factors for CoNS sepsis in NICUs, one might expect that these babies must have also been at higher risk for persistent CoNS bacteremia. This finding has been documented in other studies in the field [5,6,7,8,9,10,11,14,15,16,17,18,19]. On the other hand, this particular neonatal population is more likely to have prolonged hospital stays and invasive procedures, which could, in turn, facilitate the development of persistent disease. In other words, it cannot be clear which is the actual route of the problem: host susceptibility or environmental factors. The latter might account for the lack of correlation found in our study between weight/gestational age with a persistent form of the disease. In addition, the population studied included a rather small number of extremely premature and very low birth weight babies, and therefore, differences could not be demonstrated.
Although there was a trend for the higher presence of ica operon or biofilm production in the group of persistent bacteremia, the presence of either of them was not statistically significantly associated with the development of the persistent form of the disease. This is contrary to the finding of the study conducted ten years ago in the same NICU [17]. Overall, we had fewer isolates producing biofilm or carrying ica operon, which might account for the absence of correlation between them and persistent disease. We could also hypothesize though that the population of pathogens has changed throughout the decade and gradually became less virulent. It could be perhaps that the implementation of infection control practices and restrictions on antibiotics use might have led to less pressure on CoNS. As a result, the isolated strains appeared less virulent. We acknowledge that the small number in each group might limit the validity of any conclusions. With regards to the role of ica operon it is worth mentioning that in previous studies, the presence of ica operon was not related to persistent bacteremia [29]. In addition, in the study conducted in our institution ten years ago, no significant difference in the distribution of the ica operon between persistent and non-persistent groups was found [17]. These findings reinforce the opinion that several mechanisms besides PIA synthesis are responsible for bacterial adhesion and hence biofilm production [30].
With regards to the biofilm formation and resistance to the antibiotic of Staphylocci, the exact mechanism is not yet clear. It is highly probable that multiple factors work together to protect biofilm cells from antibiotic treatment. The matrix plays an important role in antibiotic resistance by limiting antimicrobial agents’ penetration into the biofilm and by providing physical protection to the aggregated biofilm cells [31]. As we know, some bacteria harbor antibiotic-resistant genes on plasmids. In biofilms, the frequency of horizontal plasmid transfer is much higher than between planktonic cells. Moreover, biofilm cells have a small metabolic, growth and division rate. These features make biofilm bacteria insensitive to antibiotic drugs that target dividing cells. In biofilms, there is a small subpopulation of cells called persister cells. These cells act as disease reservoirs that could reactivate into infectious particles once the antibiotic stress has been removed [31].
In the logistic regression analysis, intubation and central indwelling catheters were not found to be independently associated with the risk for persistent disease. This could be explained by the fact that these factors could account for the development of late-onset CoNS sepsis but not necessarily for the more aggressive form of the disease. The latter could be triggered by certain CoNS virulent factors, such as their ability to produce biofilm [30]. The logistic regression analysis in our cohort highlighted the role of biofilm formation as an independent factor accounting for the development of CoNS bacteremia.
The limitations of the study need to be acknowledged. First, it is a retrospective and single-institution study. Second, only the presence of icaA and icaD genes were measured as markers of ica positive genotype, and it could be that the expression of other genes might account for CoNS virulence. Third, we did not investigate the role of other proteins that might affect biofilm formation. In addition, we cannot be certain as to whether the decrease in the incidence of persistent disease is due to the improvement of infection control practices or due to the change in the molecular characteristics of the CoNS per se, making them less virulent. Finally, in order to assess more accurately trends in incidence, clinical and microbiological profile of persistent CoNS bacteremia, we ideally need an annual recording of cases for a longer period.

4. Materials and Methods

Neonates with late-onset CoNS bacteremia were studied over a 2-year period, 2016–2017, and compared to data from 2006–2007 [17]. This study was performed in the NICU of the University General Hospital of Patras, Greece, a level III referral unit, from January 2016 to December 2017. The study was approved by the Ethics Committee of the University General Hospital of Patras (806/11.12.2018). Informed parental consent was not required as the patient data were analyzed anonymously.
All neonates diagnosed with late-onset CoNS sepsis, defined as at least one positive blood culture drawn after 72 h of age in the presence of signs of infection, were identified, and those with persistent CoNS bacteremia were used for data extraction. Persistent CoNS bacteremia was defined as three or more consecutive positive blood cultures with the same CoNS species, at least 48 h apart, during a single septic episode. Neonates with two blood cultures with different susceptibilities were excluded from the study. All blood samples for culture were obtained by peripheral venipunctures with a sterile technique after appropriate skin disinfection. Demographical, clinical and microbiological variables at the onset of the septic episode (defined as the time of the first obtained positive blood culture) were reviewed from our medical records.
Demographic data, including sex, gestational age, birth weight and postnatal age, were collected from the patients’ chart reviews. The presence of risk factors for CoNS sepsis was also reviewed and included: intubation, use of central indwelling catheter and total parenteral nutrition (TPN) administration.
The clinical profile of neonates was evaluated on the basis of clinical manifestations at the onset of the septic episode, which included temperature instability (rectal temperature of <36.5 °C or >37.5 °C), respiratory deterioration (increased number of oxygen desaturations, increase in oxygen requirement, need for ventilatory support and increased number of apneas), circulatory deterioration (hypotension and signs of peripheral hypoperfusion) and feeding intolerance (abdominal distension or significant aspiration of gastric residue, that required a decrease of >20% or cessation of feeding for at least 24 h). The minimum platelet counts during the septic episode (a platelet count of <80 × 109/L was defined as thrombocytopenia, whereas a platelet count of <30 × 109/L was defined as severe thrombocytopenia), the C-reactive protein (CRP) values at the onset of sepsis, maximum CRP levels during the septic episode and the time from the onset of sepsis to the maximum CRP levels were evaluated.
Blood cultures were processed in the microbiology laboratory of our institution according to regular practice into BacT/ALERT PF pediatric FAN vials of the BacT/ALERT 3D system for aerobic and anaerobic bacteria (bioMerieux SA, Marcy-l’Etoile, France). CoNS were identified on the basis of colony morphology, Gram stain, and positive catalase and negative coagulase test results (Slidex Staph Plus; bioMerieux, Marcy-l’Etoile, France). Species identification was performed with the VITEK 2 System (bioMerieux, Marcy-l’Etoile, France). When phenotypic identification showed efficacy lower than 99%, a molecular method based on the tuf gene was applied [32]. Biofilm formation was tested by the quantitative microtitre plate assay using the reference S. epidermidis ATCC35984 (RP62A), slime producing/ica-positive strain, and ATCC12228, slime-negative/ica-negative strain, as positive and negative controls, respectively [33]. Amplification of two genes of the ica operon (icaA and icaD) as well as the mecA genes (encoding penicillin-binding protein 2a, conferring resistance to methicillin) was performed by PCRs with specific primers, according to previously described protocols [34,35].
Categorical variables are expressed as absolute and relative frequencies, while continuous variables are presented as means ± standard deviations. The chi-square test was used for comparisons between categorical variables with parametric data distribution, whereas the Mann–Whitney U-test was used for comparisons of not normally distributed data. For continuous variables, normally distributed t-test was used. To assess the effect of various factors on predicting the risk of persistent CoNS bacteremia, binary logistic regression analysis was used. The regression analysis results are expressed as the coefficients of model (β) and their standard errors (SE). Statistics were performed using the SPSS v.17 software (SPSS, Chicago, IL, USA). The level of significance was set to 0.05 for all analyses.

5. Conclusions

In conclusion, in the present study, persistent CoNS sepsis cases in our NICU have declined within a decade, which could be attributed to the implementation of more structured and intensive infection control practices. This persistent pattern of sepsis was found to be related to the most known molecular characteristics previously described, with biofilm production being the most important. To our knowledge, similar studies have not addressed this issue so far. Further studies are required to assess trends and differences in the patterns of persistent CοNS bacteremia over time and to assess the impact of antimicrobial stewardship interventions and preventative measures of hospital-acquired infections.

Author Contributions

Conceptualization, G.D. and D.G.; methodology, V.B., G.D., D.G., I.S. and N.G.; software, V.B. and A.V.; validation, D.G. and G.D.; formal analysis, V.B. and D.G.; investigation, G.D., D.G., I.S. and N.G.; resources, G.D., D.G., I.S. and N.G.; data curation, G.D., D.G., I.S., N.G. and V.B..; writing—original draft preparation, V.B. and D.G.; writing—review and editing, D.G., I.S., A.V. and G.D.; visualization, D.G.; supervision, D.G. and G.D.; project administration, V.B., G.D., D.G., I.S. and N.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Research and Ethics Committee of the University General Hospital of Patras (decision number (806/11.12.2018)).

Informed Consent Statement

Not required as data were analyzed retrospectively and anonymously.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. De Buck, J.; Ha, V.; Naushad, S.; Nobrega, D.; Luby, C.; Middleton, J.; De Vliegher, S.; Barkema, H. Non-aureus Staphylococci and Bovine Udder Health: Current Understanding and Knowledge Gups. Vet. Infect. Dis. 2021, 8, 658031. [Google Scholar] [CrossRef] [PubMed]
  2. Widerström, M.; Wiström, J.; Sjöstedt, A.; Monsen, T. Coagulase-negative staphylococci: Update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 31, 7–20. [Google Scholar] [CrossRef] [PubMed]
  3. Venkatesh, M.; Placencia, F.; Weisman, L. Coagulase-negative staphylococcal infections in the neonate and child: An update. Semin. Pediatr. Infect. Dis. 2006, 17, 120–127. [Google Scholar] [CrossRef] [PubMed]
  4. Wei, S.H.; Chiu, H.H.; Hung, K.C. Epidemiologic trends in nosocomial bacteremia in a neonatal intensive care unit. J. Microbiol. Immunol. Infect. 2005, 38, 283–288. [Google Scholar] [PubMed]
  5. Van den Hoogen, A.; Gerards, L.J.; Verboon-Maciolek, M.A. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology 2010, 97, 22–28. [Google Scholar] [CrossRef]
  6. Hornik, C.P.; Fort, P.; Clark, R.H. Early and late onset sepsis in very-low-birthweight infants from a large group of neonatal intensive care units. Early Hum. Dev. 2012, 88, S69–S74. [Google Scholar] [CrossRef] [Green Version]
  7. Vergnano, S.; Menson, E.; Kennea, N.; Embleton, N.; Russell, A.B.; Watts, T.; Robinson, M.J.; Collinson, A.; Heath, P.T. Neonatal infections in England: The NeonIN surveillance network. Arch. Dis. Child. Fetal Neonatal Ed. 2011, 96, F9–F14. [Google Scholar] [CrossRef] [Green Version]
  8. Gkentzi, D.; Kortsalioudaki, C.; Cailes, B.C.; Zaoutis, T.; Kopsidas, J.; Tsolia, M.; Spyridis, N.; Siahanidou, S.; Sarafidis, K.; Heath, P.T.; et al. Neonatal Infection Surveillance Network in Greece. Epidemiology of infections and antimicrobial use in Greek Neonatal Units. Arch. Dis. Child. Fetal Neonatal Ed. 2019, 104, F293–F297. [Google Scholar] [CrossRef]
  9. Auriti, C.; Maccallini, A.; Di Liso, G.; Di Ciommo, V.; Ronchetti, M.P.; Orzalesi, M. Risk factors for nosocomial infections in a neonatal intensive-care unit. J. Hosp. Infect. 2003, 53, 25–30. [Google Scholar] [CrossRef]
  10. Craft, A.; Finer, N. Nosocomial coagulase negative staphylococcal (CONS) catheter-related sepsis in preterm infants: Definition, diagnosis, prophylaxis, and prevention. J. Perinatol. 2001, 21, 186–192. [Google Scholar] [CrossRef]
  11. Okada, Y.; Klein, N.J.; Van Saene, H.K.; Webb, G.; Holzel, H.; Pierro, A. Bactericidal activity against coagulase-negative staphylococci is impaired in infants receiving long-term parenteral nutrition. Ann. Surg. 2000, 231, 276–281. [Google Scholar] [CrossRef] [PubMed]
  12. Saiman, L. Strategies for prevention of nosocomial sepsis in the neonatal intensive care unit. Curr. Oopin. Pediatr. 2006, 18, 101–106. [Google Scholar] [CrossRef] [PubMed]
  13. Healy, C.M.; Palazzi, D.L.; Edwards, M.S.; Campbell, J.R.; Baker, C.J. Features of invasive staphylococcal disease in neonates. Pediatrics 2004, 11, 953–961. [Google Scholar] [CrossRef] [PubMed]
  14. Cantey, J.B.; Anderson, K.R.; Kalagiri, R.R.; Mallett, L.H. Morbidity and mortality of coagulase-negative staphylococcal sepsis in very-low-birth-weight infants. World J. Pediatr. 2018, 14, 269–273. [Google Scholar] [CrossRef]
  15. Khashu, M.; Osiovich, H.; Henry, D.; Al Khotani, A.; Solimano, A.; Speert, D.P. Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit. Pediatrics 2006, 117, 340–348. [Google Scholar] [CrossRef]
  16. Anderson-Berry, A.; Brinton, B.; Lyden, E.; Faix, R.G. Risk factors associated with development of persistent coagulase-negative staphylococci bacteremia in the neonate and associated short-term and discharge morbidities. Neonatology 2010, 99, 23–31. [Google Scholar] [CrossRef]
  17. Dimitriou, G.; Fouzas, S.; Giormezis, N.; Giannakopoulos, I.; Tzifas, S.; Foka, A. Clinical and microbiological profile of persistent coagulase-negative staphylococcal bacteremia in neonates. Clin. Microbiol. Infect. 2011, 17, 1684–1690. [Google Scholar] [CrossRef] [Green Version]
  18. Linder, N.; Hernandez, A.; Amit, L.; Klinger, G.; Ashkenazi, S.; Levy, I. Persistent coagulase-negative staphylococci bacteremia in very-low-birth-weight infants. Eur. J. Pediatr. 2011, 170, 989–995. [Google Scholar] [CrossRef]
  19. Furuichi, M.; Miyairi, I. Risk factors for persistent bacteremia in infants with catheter-related bloodstream infection due to coagulase-negative Staphylococcus in the neonatal intensive care unit. J. Infect. Chemother. 2016, 22, 785–789. [Google Scholar] [CrossRef]
  20. O’Gara, J.P.; Humphreys, H. Staphylococcus epidermidis biofilms: Importance and implications. J. Med. Microbiol. 2001, 50, 582–587. [Google Scholar] [CrossRef] [Green Version]
  21. Foster, T.J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 2005, 3, 948–958. [Google Scholar] [CrossRef] [PubMed]
  22. Vogel, L.; Sloos, J.; Spaargaren, J.; Suiker, I.; Dijkshoorn, L. Biofilm production by Staphylococcus epidermidis isolates associated with catheter related bacteremia. Diagn. Microbiol. Infect. Dis. 2000, 36, 139–141. [Google Scholar] [CrossRef]
  23. Rohde, H.; Frankenberger, S.; Zahringer, U.; Mack, D. Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections. Eur. J. Cell Biol. 2009, 89, 103–111. [Google Scholar] [CrossRef] [PubMed]
  24. Heilmann, C.; Schweitzer, O.; Gerke, C.; Vanittanakom, N.; Mack, D.; Gotz, F. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol. Microbiol. 1996, 20, 1083–1091. [Google Scholar] [CrossRef]
  25. Stewart, P.S.; Costerton, J.W. Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358, 135–138. [Google Scholar] [CrossRef]
  26. Manandhar, S.; Singh, A.; Varma, A.; Pandey, S.; Shrivastava, N. Phenotypic and genotypic characterization of biofilm producing clinical coagulase negative staphylococci from Nepal and their antibiotic susceptibility pattern. Ann. Clin. Microbiol. Antimicrob. 2021, 20, 41. [Google Scholar] [CrossRef]
  27. John-Ugwuanya, A.; Obaro, G.; Obaro, S. A Systematic Review of Coagulase-Negative Staphylococci in Neonatal Sepsis. Clin. Microbiol. 2019, 8, 326. [Google Scholar] [CrossRef]
  28. Ceballos, K.; Waterman, K.; Hulett, T.; Beth Flynn Makic, M. Nurse-Driven Quality Improvement Interventions to Reduce Hospital-Acquired Infection in the NICU. Adv. Neonatal Care 2013, 13, 154–163. [Google Scholar] [CrossRef]
  29. Harris, L.G.; Murray, S.; Pascoe, B.; Bray, J.; Meric, G.; Mageiros, L.; Wilkinson, T.S.; Jeeves, R.; Rohde, H.; Schwarz, S.; et al. Biofilm Morphotypes and Population Structure among Staphylococcus epidermidis from Commensal and Clinical Samples. PLoS ONE 2016, 11, e0154510. [Google Scholar] [CrossRef]
  30. Arciola, C.R.; Campoccia, D.; Ravaioli, S.; Montanaro, L. Polysaccharide intercellular adhesin in biofilm: Structural and regulatory aspects. Front. Cell. Infect. Microbiol. 2015, 5, 7. [Google Scholar] [CrossRef] [Green Version]
  31. Rabin, N.; Zheng, Y.; Opoku-Temeng, C.; Du, Y.; Bonsu, E.; Sintim, H.O. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Med. Chem. 2015, 7, 493–512. [Google Scholar] [CrossRef]
  32. Kontos, F.; Petinaki, E.; Spiliopoulou, I.; Maniati, M.; Maniatis, A. Evaluation of a novel method based on PCR restriction fragment length polymorphism analysis of the tuf gene for the identification of Staphylococcus species. J. Microbiol. Methods 2003, 55, 465–469. [Google Scholar] [CrossRef]
  33. Stepanović, S.; Vuković, D.; Hola, V.; Di Bonaventura, G.; Djukić, S.; Cirković, I.; Ruzicka, F. Quantification of biofilm in microtiter plates: Overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 2007, 115, 891–899. [Google Scholar] [CrossRef]
  34. Arciola, C.R.; Campoccia, D.; Gamberini, S.; Cervellati, M.; Donati, E.; Montanaro, L. Detection of slime production by means of an optimised Congo red agar plate test based on a colourimetric scale in Staphylococcus epidermidis clinical isolates genotyped for ica locus. Biomaterials 2002, 23, 4233–4239. [Google Scholar] [CrossRef]
  35. Petinaki, E.; Arvaniti, A.; Dimitracopoulos, G.; Spiliopoulou, I. Detection of mecA, mecR1 and mecI genes among clinical isolates of methicillinresistant staphylococci by combined polymerase chain reactions. J. Antimicrob. Chemother. 2001, 47, 297–304. [Google Scholar] [CrossRef] [Green Version]
Table 1. Demographics, clinical and laboratory characteristics of the studied population (n = 56), cases with persistent (n = 14) and cases with non-persistent (n = 42) CoNS bacteremia the period 2016–2017.
Table 1. Demographics, clinical and laboratory characteristics of the studied population (n = 56), cases with persistent (n = 14) and cases with non-persistent (n = 42) CoNS bacteremia the period 2016–2017.
DemographicsAll Cases
n = 56
Persistent
n = 14
Non-Persistent
n = 42
p Value
Gender
Male28 5 23 0.217 a
Female28 9 19
Gestational age (weeks) *33.6 (3.7)34.4 (3.2)33.3 (3.9)0.403 b
Birth weight (g) *2102 (973)2142 (823)2090 (1025)0.887 b
Clinical practice risk factors
Intubation153 12 0.601 a
Central indwelling catheters52 3 0.231 a
Parenteral nutrition246 18 0.877 a
Clinical characteristics
Temperature instability289 19 0.272 b
Food intolerance318 23 0.877 a
Respiratory deterioration 164 12 0.601 a
Circulatory deterioration74 3 0.036 a
Laboratory indices
Thrombocytopenia (<80 × 109/L)73 4 0.243 a
Severe thrombocytopenia (<30 × 109/L)21 1 0.406 a
Maximum CRP (mg/dL) *7.1(5.4)12 (4.7)5.4 (4.8)0.000 b
Days up to maximum CRP *1.96(0.9)2.71 (1.3)1.71 (0.7)0.001 b
a: χ2; b: t-test. * Data are presented as mean and SD into brackets.
Table 2. Comparison of characteristics among neonates with CoNS bacteremias between the periods 2006–2007 (n = 72) and 2016–2017 (n = 56).
Table 2. Comparison of characteristics among neonates with CoNS bacteremias between the periods 2006–2007 (n = 72) and 2016–2017 (n = 56).
Demographics2006–2007
n = 72
2016–2017
n = 56
p Value
Gender
Male41 28 0.589 a
Female31 28
Gestational age (weeks) *32.6 (3.8)33.6 (3.7)0.164 b
Birth weight (g) *2124 (735)2102 (973)0.888 b
Clinical practice risk factors
Intubation28 15 0.111 a
Central indwelling catheters33 5 0.000 a
Parenteral nutrition41 24 0.114 a
Clinical characteristics
Temperature instability52 28 0.038 a
Food intolerance40 31 0.982 a
Respiratory deterioration 30 16 0.144 a
Circulatory deterioration41 7 0.000 a
Laboratory indices
Thrombocytopenia (<80 × 109/L)37 7 0.000 a
Severe thrombocytopenia (<30 × 109/L)25 2 0.000 a
Maximum CRP (mg/dL) *8.1(6.091)7.1(5.4)0.330 b
Days up to maximum CRP *2.16 (1.0)1.96 (0.9)0.279 b
a: χ2; b: t-test; * data are presented as mean and SD into brackets.
Table 3. Comparison of characteristics among neonates between the periods 2006–2007 and 2016–2017 for the cases with persistent CoNS bacteremia and with non-persistent CoNS bacteremia.
Table 3. Comparison of characteristics among neonates between the periods 2006–2007 and 2016–2017 for the cases with persistent CoNS bacteremia and with non-persistent CoNS bacteremia.
DemographicsCases with Persistent CoNS
Bacteremia
Cases with Non-Persistent CoNS
Bacteremia
2006–2007
n = 29
2016–2017
n = 14
2006–2007
n = 43
2016–2017
n = 42
Gender
Male16 5 25 23
Female13 918 19
Gestational age (weeks) * 32 (3.8)34.4 (3.2)33 (3.7)33.3 (3.9)
Birth weight (g) *1940 (736)2142 (823)2200 (725)2090 (1025)
Clinical practice risk factors
Intubation16 3 **12 12
Central indwelling catheters18 2 ***15 3 ***
Parenteral nutrition 17 6 24 18
Clinical characteristics
Temperature instability24 9 28 19
Food intolerance19 821 23
Respiratory deterioration 14 4 16 12
Circulatory deterioration19 4 ***22 3 **
Laboratory indices
Thrombocytopenia (<80 × 109/L)27 3 **10 4
Severe thrombocytopenia (<30 × 109/L)22 1 **3 1
Maximum CRP (mg/dL) *8.9 (6.1)12 (4.7)4.0 (3.3)5.4 (4.8)
Days up to maximum CRP *2 (0.7)2.71 (1.3) **3 (1.0)1.71 (0.7) **
* Data are presented as mean and SD into brackets. ** p < 0.001; *** p< 0.05.
Table 4. Comparison of molecular characteristics of CoNS isolates causing persistent and non-persistent bacteremias throughout the two studied periods.
Table 4. Comparison of molecular characteristics of CoNS isolates causing persistent and non-persistent bacteremias throughout the two studied periods.
Persistent vs.
Non-Persistent
(2016–2017)
All CasesPersistentNon-Persistent
Study Period2016–20172016–20172006–20072016–20172006–20072016–20172006–20072016–2017
Number of isolates986917016797987369
ica-positive50 25 129 75 *74 50 *5525 *
Biofilm-positive50 26 107 76 *68 50 **39 26 **
ica-positive/biofilm-positive50 22 91 72 59 50 32 22
ica-positive/biofilm-negative0 3 373 *140 *23 3 *
ica-negative/biofilm-negative43 45 2588 *1443 *11 45 *
ica-negative/biofilm-positive0 4 16 4 **90 **7 4
mecA-positive88 69 *166 15793 88 73 69
* p < 0.001; ** p < 0.05.
Table 5. Binary logistic regression analysis assessing parameters that might predict the risk of persistent CoNS bacteremia the period 2016–2017.
Table 5. Binary logistic regression analysis assessing parameters that might predict the risk of persistent CoNS bacteremia the period 2016–2017.
βExp (β)SESig.95% for Exp (β)
LowerUpper
Intubation0.2111.2351.1430.8540.13211.591
Central indwelling catheters1.0172.7661.0790.3460.33422.932
Severe thrombocytopenia (<30 × 109)3.58736.1391.2640.0053.03743.083
Biofilm production2.46411.7471.2100.0421.095125.979
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Bellou, V.; Gkentzi, D.; Giormezis, N.; Vervenioti, A.; Spiliopoulou, I.; Dimitriou, G. Persistent Coagulase-Negative Staphylococcal Bacteremia in Neonates: Clinical, Microbiological Characteristics and Changes within a Decade. Antibiotics 2022, 11, 765. https://doi.org/10.3390/antibiotics11060765

AMA Style

Bellou V, Gkentzi D, Giormezis N, Vervenioti A, Spiliopoulou I, Dimitriou G. Persistent Coagulase-Negative Staphylococcal Bacteremia in Neonates: Clinical, Microbiological Characteristics and Changes within a Decade. Antibiotics. 2022; 11(6):765. https://doi.org/10.3390/antibiotics11060765

Chicago/Turabian Style

Bellou, Venetia, Despoina Gkentzi, Nikolaos Giormezis, Aggeliki Vervenioti, Iris Spiliopoulou, and Gabriel Dimitriou. 2022. "Persistent Coagulase-Negative Staphylococcal Bacteremia in Neonates: Clinical, Microbiological Characteristics and Changes within a Decade" Antibiotics 11, no. 6: 765. https://doi.org/10.3390/antibiotics11060765

APA Style

Bellou, V., Gkentzi, D., Giormezis, N., Vervenioti, A., Spiliopoulou, I., & Dimitriou, G. (2022). Persistent Coagulase-Negative Staphylococcal Bacteremia in Neonates: Clinical, Microbiological Characteristics and Changes within a Decade. Antibiotics, 11(6), 765. https://doi.org/10.3390/antibiotics11060765

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop